Showing results (1241-1250 of 3,182) with videos related to

Sort By:
Pageof 319
Translational Oncology|August 19, 2022
Anlotinib exerts potent antileukemic activities in Ph chromosome negative and positive B-cell acute lymphoblastic leukemia via perturbation of PI3K/AKT/mTOR pathwayQiuling Chen, Qian Lai, Yuelong Jiang, et al.
Translational Oncology|August 4, 2022
PVR/TIGIT and PD-L1/PD-1 expression predicts survival and enlightens combined immunotherapy in lung squamous cell carcinomaZhenlin Yang, Yue Peng, Jiachen Xu, et al.
Translational Oncology|February 22, 2023
HER2 as a potential therapeutic target on quiescent prostate cancer cellsKenji Yumoto, Jibraan Rashid, Kristina G Ibrahim, et al.
Translational Oncology|March 24, 2023
The mechanisms underlying the enrichment and action of glypican-1-positive exosomes in colorectal cancer cellsJian Li, Yuxiang Chen, Shuyi Yu, et al.
Translational Oncology|May 4, 2021
A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomasXuyan Pan, Zhaopeng Wang, Fang Liu, et al.
Translational Oncology|May 17, 2021
Pulmonary enteric adenocarcinomaJiali Gong, Ying Fan, Hongyang Lu
Translational Oncology|May 27, 2020
Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant RangeWilliam Hankey, Benjamin Sunkel, Fuwen Yuan, et al.
Translational Oncology|May 26, 2020
Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer TreatmentUttam Sharma, Tushar Singh Barwal, Varnali Acharya, et al.
Translational Oncology|May 26, 2020
Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular ProfilingGrace Davies, Phyllis Butow, Christine E Napier, et al.
Translational Oncology|August 13, 2021
Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessmentsHiroyuki Suzuki, Hideki Iwamoto, Masahito Nakano, et al.
Pageof 319